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Abstract  
Despite the growing global burden of alcoholic liver diseases, therapeutic options are limited 
and novel targets are urgently needed. Accumulating evidence suggests that mitochondria 
adapt in response to ethanol and formation of megamitochondria in the livers of patients is 
recognized as a hallmark of alcoholic liver diseases. The processes involved in ethanol-
induced hepatic mitochondrial changes, the impact on mitochondria-shaping proteins, and 
the significance of megamitochondria formation remain unknown. In this study, we 
investigated the mitochondrial and cellular response to alcohol in hepatoma cell line VL-17A. 
The mitochondrial architecture rapidly changed after 3 or 14 days of ethanol exposure with 
double-pronged presentation of hyper-fragmentation and megamitochondria and cell growth 
was inhibited. Dynamin-1-like protein (Drp1) was identified as the main mediator driving 
these mitochondrial alterations and its genetic inactivation was determined to foster 
megamitochondria development, preserving the capacity of the cells to grow despite alcohol 
toxicity. The role of Drp1 in mediating megamitochondria formation in mice with liver-specific 
inactivation of Drp1 was further confirmed. Finally, when these mice were fed with ethanol, 
the presentation of hepatic megamitochondria was exacerbated compared to wild type fed 
with the same diet. Ethanol-induced toxicity was also reduced. Our study demonstrates that 
megamitochondria formation is mediated by Drp1 and this phenomenon is a beneficial 
adaptive response during alcohol-induced hepatotoxicity.  
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Introduction  
Alcoholic liver diseases (ALD) encompass a number of clinical presentations ranging from 
simple steatosis to steatohepatitis, fibrosis, and cirrhosis and can also manifest as severe 
alcoholic hepatitis. The pathobiology of ALD is not fully elucidated and this has led to a lack 
of treatment options for this disorder which represents one of the 10 most common causes 
of death in the Western World1.  
Mitochondria play an essential role within the complex disease processes associated with 
ALD not only as the central location for alcohol metabolizing enzymes, but also as active 
mediators in the response to alcohol toxicity2, 3. In hepatocytes, ethanol oxidation perturbs 
the homeostasis of several mitochondrial pathways involved in glucose/lipid metabolism and 
energy conversion. Ethanol also dramatically increases oxidative stress, which directly 
drives changes in mitochondrial proteins, lipids, and mitochondrial DNA affecting 
functionality and cellular viability4. Importantly, the morphology and the functionality of 
mitochondria are strictly correlated and mitochondrial dynamics, with cycles of fusion 
(binding of two organelles) and fission (mitochondrial fragmentation) constantly adjusting 
mitochondrial shape to maintain a pool of fully operative organelles. The balance between 
mitochondrial fusion and fission determines the architecture of the mitochondrion which is 
necessary for the preservation of cellular and tissue integrity. These processes regulate the 
selective removal of damaged organelles (mitophagy) through fission and the maintenance 
of the bioenergetic efficiency through fusion5. Fusion and fission are driven primarily through 
the activity of multiple “mitochondria-shaping proteins” (MSP) which act together to maintain 
a balance between these two antagonistic events6. When either process is blocked, the final 
morphology of the mitochondrion is the consequence of unopposed progression towards the 
other side of the equilibrium. Although new members of this family are continuing to be 
discovered, the best characterized include Mitofusin-1 and -2 (Mfn1, Mfn2), which localize on 
the outer mitochondrial membrane and are essential for mitochondrial tethering to initiate the 
fusion process7. Conversely, dynamin-1-like protein (Drp1, gene: DNM1L) drives 
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fragmentation; this cytosolic GTPase protein when activated translocates to mitochondria 
and assembles in multimers to constrict and fragment the organelle8-10. Several proteins 
localized on the outer mitochondrial membrane have been proposed as Drp1 receptors, 
including mitochondrial fission 1 protein (Fis1), mitochondrial fission factor (Mff), and 
mitochondrial dynamics protein MID49 and mitochondrial dynamics protein MID5111; 
however, their exact mechanisms of action and the effect on mitochondrial morphology are 
still under debate12. Alterations in MSP or in the equilibrium between fusion and fission have 
been associated with the pathogenesis of several neurodegenerative and metabolic 
disorders13, 14. 
The current study elucidates the impact of ethanol on mitochondrial morphology in the liver 
and identifies for the first time the main regulator involved in the morphological changes 
induced by ethanol on hepatic mitochondria, opening new perspectives for potential 
therapeutic strategies in ALD.  
Materials and methods  
Cellular models 
Human hepatoma VL-17A cell line, stably expressing alcohol dehydrogenase (ADH) and 
CYP2E115, were cultured in complete DMEM containing zeocin and geneticin at 400µg/mL in 
the presence/absence of ethanol (EtOH) at 100mM for 3 (D3) or 14 days (D14) and EtOH 
replaced at every passage. Treated cells were kept in an incubator saturated with EtOH to 
minimize evaporation (opened petri dish containing 200mM ethanol).  
Three cell models were derived from VL-17A. VL-17A cells transiently transfected with 
mitochondrially targeted RFP to label mitochondria (mtRFP; Clontech, Saint-Germain-en-
Laye, France) according to manufacturer’s guidelines (Neon transfection system, Life 
technologies, Paisley, UK). VL-17A cells transiently transfected with a plasmid expressing 
mtRFP and a Drp1 mutant (Lys 38 to Ala) that acts as dominant negative (Drp1-K38A) and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
  5                                                                                                 
   
 
disables the fragmentation activity of Drp19, 10 (pcDNA3-Drp1-K38A was a kind gift of 
Professor Luca Scorrano, University of Padova, Italy). VL-17A cells stably expressing Drp1-
K38A and/or enhanced green fluorescent protein (eGFP) generated through lentiviral 
transduction. 
Animal model 
Drp1 (Dnm1l) Flox/Flox mice (C57BL/6/129) were generated as described previously16 and 
crossed with Albumin-Cre mice (Alb-Cre, C57BL/6) (Jackson Laboratory, Bar Harbor, ME) to 
obtain mice with liver-specific inactivation of Drp1 (Dnm1l) (Alb-Cre+Drp1) and compared to 
wild type (WT, Alb-Cre-Drp1) male C57BL/6 J mice (Jackson Laboratories). Alb-Cre-Drp1 
and Alb-Cre+Drp1 mice were divided into two groups and fed either with control diet or with 
the ethanol diet NIAAA model (10-d ad libitum oral feeding with the Lieber-DeCarli ethanol 
liquid diet (5%v/v) plus a single binge ethanol feeding via gavage (5g/kg)) as previously 
described17. All animals received human care. All procedures were approved by the 
Institutional Animal Care and Use Committee of the University of Kansas Medical Center. 
Alanine aminotransferase (ALT) levels were measured in the blood of mice using a 
commercial kit (Liquid ALT Reagents, Pointe Scientific, Canton, MI). 
Plasmids, lentiviral preparation, and infection 
The bicistronic lentiviral vector pULTRA expressing eGFP was a gift from Malcolm Moore, 
Memorial Sloan-Kettering Center, New York, NY (Addgene plasmid # 24129)18 and 
pULTRA-eGFP-Drp1-K38A was obtained from cloning the Drp1-K38A DNA fragment 
isolated from pcDNA3-Drp1-K38A between BamHI and EcoRI restriction sites of pULTRA-
eGFP and confirmed by nucleotide sequencing. Lentiviral preparations were obtained, as 
previously described19. Supernatants were harvested, concentrated, and lentiviral titer 
measured with QuickTiter™ Lentivirus Titer Kit (Cambridge Bioscience, Cambridge, UK), 
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then used to infect VL-17A cell line in the presence of 8 µg/mL polybrene (Sigma, 
Gillingham, UK). 
Confocal microscopy 
Mitochondria were visualized in VL-17A cells using immunostaining as previously described7 
after staining with anti-Tom20 (BD Bioscience, Oxford, UK) and NorthernLights anti-mouse 
IgG-NL557 (R&D Systems, Minneapolis, MN) or in VL-17A cells expressing mtRFP 
with/without transient expression of Drp1-K38A. Confocal images were collected using the 
PerkinElmer spinning-disk confocal microscope UltraVIEW (Perkin Elmer, Coventry, UK). 
Morphological analysis 
1) Approximately 50 images (300 VL-17A cells) per condition were collected by confocal 
microscopy and cells were ranked according to their mitochondrial phenotype and blindly 
scored using previously reported guidelines7, 10. The three cellular phenotypes (Fig.1A) 
included: i) hyper-fragmented: cells presenting >50% of mitochondria as small and 
spherical entities (diameter<1µm); ii) mixed network: cellular presentation of 
interconnected mitochondrial network with <50% fragmented organelles and elongated 
mitochondria (length>2µm/width<1µm) concurrently; and iii) hyper-fused (mega): over-
interconnected mitochondrial structure with abnormal enlargements including discrete 
oversized megamitochondria with width and length>1µm according to previously 
reported categorization recommendations20.  
Cell growth and viability assays 
Cell growth was assessed at every passage by evaluating the number of viable cells 
(propidium iodide(-), PI) with growth rate calculated as fold increase per day. Cell 
proliferation was evaluated using the CellTrace™ Far Red Cell Proliferation Kit (Thermo 
Fisher Scientific, Basingstoke, UK), according to the manufacturer’s guidelines. Early 
apoptotic or necrotic events were detected by flow cytometric analysis, with V450 Annexin V 
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(BD Horizon; mark of apoptosis) in addition to PI (Sigma) or 7-aminoactinomycin D (7-AAD) 
(Biolegend, London, UK) staining. Data were acquired and analyzed on a FACS Canto II 
flow cytometer using FACS Diva 6.1 software (BD).  
Mitochondrial isolation 
VL-17A cells were homogenized in isolation buffer (250mM sucrose, 10mM TRIS, 1mM 
EGTA, pH 7.4) using the Precellys®24 grinder (Bertin Technologies, Montigny le Bretonneux, 
France) with ceramic bead-vials. Mitochondria were then isolated by standard differential 
centrifugations as previously described21. Mitochondrial protein concentration was quantified 
by Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).  
Western Blot Analysis 
Protein extracts were obtained from total cell lysate, mitochondrial fraction, and mouse liver 
homogenate and separated by 12% SDS-PAGE, transferred onto nitrocellulose membranes 
(GE Healthcare Bio-Sciences AB, Uppsala, Sweden) and analyzed as previously described7. 
The following antibodies (dilution 1:1000) were used: anti-Drp1, anti-Tom20 (BD 
Bioscience); anti-MiD51 (SMCR7L/MID51) (ProteinTech Europe, Manchester, UK); anti-Mff 
(Sigma); anti–Mitofusin-1, anti–Mitofusin-2, antipyruvate dehydrogenase kinase 1 (anti–
PDK1), anti-actinin (Santa Cruz biotechnology, Heidelberg, Germany); anti–β-actin, anti-
VDAC1/Porin (Abcam, Cambridge, UK).  
Mitochondrial mass 
The mitochondrial mass was quantified by flow cytometry after staining the living cells with 
20nM MitoTracker Green FM (Life Technologies) for 30 minutes at 37 ˚C according to the 
manufacturer’s protocol, in presence of 2 µg/mL Cyclosporin H (Santa Cruz Biotechnology). 
Data were acquired and analyzed on a FACS Canto II flow cytometer using FACS Diva 6.1 
software (BD).  
Mitochondrial respiration 
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Seahorse XF24 Analyzer (Seahorse Bioscience, Copenhagen, Denmark) was used to 
measure the mitochondrial oxygen consumption rate (OCR) in untreated/treated VL-17A 
cells in situ. Changes in OCR (nmoles/min) in response to oligomycin (oligo, 1µg/mL; 
Sigma), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 0.6µM; Sigma), and 
antimycin A (anti, 2µM; Sigma) were measured and used to calculate the spare respiratory 
capacity (OCRFCCP/OCRbasal) and the coupling efficiency (1-OCRoligo/OCRbasal). 
Measurements were repeated in triplicate in three separate experiments and the OCR 
values normalized for the total protein content, quantified by Pierce BCA Protein Assay Kit 
(Thermo Fisher Scientific). 
Electron Microscopy 
Cells or murine liver tissue were fixed with 2% paraformaldehyde and 1.5% glutaraldehyde 
in 0.1M cacodylate buffer or 2.5% glutaraldehyde in 0.1M phosphate buffer (pH 7.4), 
followed by 1% OSO4. After dehydration, ultrathin sections were stained with uranyl acetate 
and lead citrate and viewed in a JEM 1011CX or 1010 transition electron microscope (JEOL) 
as described previously22. The size of megamitochondria was evaluated in the cells using 
ImageJ 1.49c: images were analyzed in blind and the length and the width of 
megamitochondria (>1 µm) were measured using the straight line function across each 
organelle, followed by analyse measure.  
Statistical analysis 
Continuous variables were expressed as mean ± standard error of the mean (SEM) and 
categorical variables were described as means of counts and percentages. Comparisons 
were performed using independent or paired Student t test or non-parametric Friedman’s 
analysis of variance for repeated measures, when multiple treatment groups were analyzed 
simultaneously. Categorical variables (morphological analysis) were analyzed by Chi-square 
test. Statistics were calculated using MS Excel 2010 (Microsoft, Redmond, WA) and 
GraphPad Prism 6.07 (GraphPad, La Jolla, CA). Statistical significance was set at P < 0.05. 
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Results  
Ethanol exposure severely impairs cellular proliferation and mitochondrial 
morphology in VL-17A cells, with no impact on mitochondrial mass or functionality 
A significant impact on proliferative potential was observed in response to both short and 
long exposure of ethanol in VL-17A cells (Fig.2A, B). After the short insult the apoptotic and 
necrotic levels were not significantly different from the controls (Fig.2C), whereas longer 
alcohol exposure induced a slight but significant increase in the percentage of apoptotic cells 
(Fig.2C). The measurement of basal mitochondrial respiration rate (Fig.2D) and the 
calculation of the coupling efficiency as well as of the spare respiratory capacity were not 
different between the short and long-ethanol cultures compared to the controls (Fig.2E). The 
mitochondrial mass was also not affected by ethanol exposure (Fig.2F), but remarkable 
mitochondrial remodelling was observed by confocal and electron microscopy. The 
untreated cells presented a prevalence of interconnected mitochondrial network, with a 
balance between fusion/fission, whereas the ethanol-treated cells displayed a significantly 
different distribution among the three mitochondrial phenotypes both in day3 and day14 
cultures (Fig.1A) with more than 14% of the cells exposed to ethanol showing a hyper-
fragmented network. With extended exposure to ethanol the presence of oversized and 
misshapen megamitochondria (Fig.1B) were observed. These abnormalities were also 
detected by confocal microscopy (Fig.1A), where almost 30% of the cells exposed to day14 
ethanol were classified in the hyper-fused/ megamitochondria phenotype. 
 
Extended ethanol exposure affects mitochondrial shaping protein expression in VL-
17A cells 
Short ethanol exposure in VL-17A cells did not impact the fusion or fragmentation pathways 
(Fig.3), but prolonged ethanol treatment significantly reduced the mitochondrial translocation 
of Drp1, the main protagonist driving mitochondrial fragmentation, this was paralleled with an 
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observed increase in the Drp1 receptor Mff (Fig.3A). Ethanol did not affect the fusion 
machinery; no changes were observed in Mfn-1 or Mfn-2 (Fig.3B). In WT mice fed with 
ethanol no significant changes in Drp1 hepatic expression were detected when compared to 
control animals (Fig.3C). 
 
Drp1 inactivation promotes megamitochondria formation and abrogates ethanol-
induced cell growth retardation in hepatoma cells 
The analysis of the mitochondrial phenotypes (hyper-fragmented, mixed, and hyper-fused) 
and the evaluation of ethanol toxicity were performed in the cellular model where the 
fragmentation pathway was disabled (Drp1-K38A) in comparison to the control VL-17A with 
active Drp1. In the absence of ethanol, inactivation of Drp1 led to a notable increase in the 
appearance of hyper-fused megamitochondria (Fig.4 A). Ethanol induced fragmentation in 
the control VL-17A cells (Fig.4B) but this was completely abolished in the Drp1-K38A cells, 
which presented an additional increase in megamitochondria formation (Fig.4A). Further to 
this, the impact of ethanol on cellular growth was evaluated in the stable lines of VL-17A 
expressing both eGFP and Drp1-K38A (GFP+ Drp1-inactive) and the control cells expressing 
only eGFP (WT Drp1-active). In cultures with Drp1 active growth retardation was observed 
during ethanol exposure (Fig. 4C). However, inactivation of Drp1, with megamitochondria 
formation, rescued this growth blockade with percentage of GFP+/Drp1-K38A cells 
significantly increasing over time despite alcohol insult. Moreover, these cells showed a 
proliferative advantage compared to the GFP- cells in the same culture (Fig.4C).  
 
Drp1 inactivation causes megamitochondria development in murine livers 
The hepatic mitochondrial evaluation by electron microscopy in the mice after liver 
inactivation of Drp1 showed the formation of very enlarged and round shaped organelles 
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(Fig.5A, B) with the same morphological characteristics of megamitochondria observed in 
the cellular model after ethanol exposure (Fig.1) as well as previously reported in animal 
models fed with alcohol23 or liver biopsies from alcoholic patients24. The incidence of 
megamitochondria was significantly increased in the liver of these mice after inactivation of 
Drp1 (Alb-Cre+Drp1) compared to the WT (Alb-Cre-Drp1) (Fig.5C).  
 
Ethanol exposure causes megamitochondria formation in murine livers and Drp1 
inactivation exacerbates this phenomenon and reduces ethanol-induced 
hepatotoxicity 
In both WT mice (Alb-Cre-Drp1) and mice with inactive hepatic Drp1 (Alb-Cre+Drp1) the 
ethanol diet induced a significant increase in the percentage of megamitochondria (Fig.5A, 
B, C), and this effect was significantly more pronounced in mice with inactive Drp1 when 
compared to WT (Fig.5C). The effect of ethanol on ALT levels was also analyzed and these 
values were found to be significantly increased in WT mice, but not in mice with inactive 
Drp1 as shown from the ratios of ethanol vs control diet (Fig.5D). 
 
Discussion 
One of the main findings of this study was the profound impact of ethanol on hepatic 
mitochondrial morphology, including both organelle fragmentation and enlargement. Both 
short and long exposure of ethanol induced an increase in the hyper-fragmented 
mitochondrial fraction confirming ethanol-related augmented fission which has previously 
only been reported in other cell types including human retinal pigment epithelial cells25, 26 and 
alveolar macrophages27.  In the hepatoma cell model, ethanol exposure caused an 
immediate change in mitochondrial shape with significant imbalance of the fusion/fission 
equilibrium, which was confirmed by the changes in MSP expression observed. These 
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results suggest that mitochondrial dynamics play an essential role in alcohol-related liver 
disease and support other studies which have observed hepatic mitochondrial remodelling 
during alcoholic insults28, 29. In addition, after the prolonged exposure, hyper-fragmentation 
was accompanied by the formation of disproportionately enlarged megamitochondria. These 
architectural alterations in hepatic mitochondria were similar to the presentation of enlarged 
and hyper-fused organelles previously identified in patients and animal models, as one of the 
consequences of chronic ethanol consumption. Indeed, the detection of megamitochondria 
in liver biopsies has been regarded as a specific hallmark for alcohol-related liver disease 
since the 1970s23, 30, 31. In this study extended ethanol exposure induced the formation of 
megamitochondria in the VL-17A cells, endorsing for the first time the validity of this cell line 
in studying the phenomenon.  
These data suggest that the appearance of megamitochondria after a prolonged/chronic 
stimulus alongside mitochondrial hyper-fragmentation, is an adaptive mechanism possibly to 
counteract excessive fission and mitophagy, which unregulated would be highly detrimental 
to cellular survival32, 33. This seems to represent a response of the hepatocytes to preserve 
cellular function in the face of a toxic insult with mitochondrial fragmentation facilitating the 
clearance of dysfunctional organelles via mitophagy. This is supported by reports 
demonstrating that alcohol stimulates the initiation of autophagy34, 35 and that damaged 
mitochondria and accumulated lipid droplets are the selective target of autophagy induced 
by acute ethanol exposure36.  
In addition, this study identified for the first time the master fission mediator Drp1 as the key 
player involved in the alcohol-related morphological changes. In our cellular model, the 
expression of mutated dominant-negative Drp1 (Drp1-K38A) was sufficient to abolish the 
ethanol-induced mitochondrial hyper-fragmentation and one of the most striking results was 
the beneficial effect on cell proliferation of Drp1 inhibition in response to ethanol insult. In 
control cells with active Drp1, ethanol was able to induce a significant growth retardation 
even after three days of exposure. Indeed, ALD is known to be associated with a significant 
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loss of hepatocyte proliferation and impaired regeneration, further driving the inability of the 
liver to deal with the toxic insult due to a reduced capacity to replace dying hepatocytes. This 
is an area of much interest and many clinical trials are trying to find ways to promote 
hepatocyte proliferation37. Drp1 inactivation in the VL-17A cells showed a protective effect 
with the rescue of cell growth retardation induced by ethanol both at 3 and 14 days of toxic 
exposure. The toxic effect in terms of cell death was probably too mild to be appreciated in 
this model (data not shown). More importantly, Drp1 inactivation showed a beneficial effect 
also in the mouse model where the ethanol exposure did not induce significant changes in 
the release of alanine aminotransferase. This finding is particularly relevant considering the 
significant and escalating clinical burden of alcohol-related liver disease and therefore the 
urgent need to develop specific and targeted drugs. Currently, the cornerstone of therapy 
remains abstinence with supportive treatments and few other options with limited efficacy38. 
There are no therapies aimed at stopping ongoing ethanol toxicity in hepatocytes, to halt 
injury and allow time for regeneration and repair. This study gives the initial experimental 
evidence that targeting mitochondrial dynamics could reduce liver injury by improving the 
adaptation of hepatocytes to alcohol toxicity. Moreover, it has been recently demonstrated 
that Drp1 inhibition has a beneficial and protective effect in several other models of liver 
injury, including hepatotoxicity induced by toxic agents (senecionine39 and cadmium40), in 
animal models of diet-induced steatosis41 and cholestatic liver injury42.  
The most important finding of this study is that Drp1 inhibition is able to cause a rapid and 
extensive formation of megamitochondria, which was confirmed in mouse models with liver-
specific inactivation of Drp1. The molecular mechanisms regulating the development of 
these morphological abnormalities and their influence on cellular responses have not been 
elucidated to date, but several clinical studies have endorsed the presence of intrahepatic 
megamitochondria in ALD as beneficial clinical indicators43-46. Moreover, a recent study has 
reported that the treatment with Drp1 inhibitor Mdivi-1 in Triticum aestivum caused fission 
retardation with consequent induction of megamitochondria and this has been recognized as 
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a strategic adaptation of plants to stress47. The prospect for the use of Drp1 inhibitors in vivo 
has also become more promising after the demonstration of their prophylactic and 
therapeutic effects in several models of tissue injury, induced by toxic insult or 
ischemia/reperfusion damage48-53. The beneficial advantage of these agents in alcohol-
induced liver injury may also be two-pronged due to a decrease of oxidative stress, as 
associated with Drp1 inhibitors treatment in a murine cardiac arrest model54, which plays a 
fundamental role in alcohol-related hepatotoxicity.  
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Figure Legends 
Figure 1. Ethanol (EtOH) severely affects mitochondrial morphology in VL-17A cells. 
A: After mitochondrial immunostaining using anti-Tom20 antibody, cells were classified 
according to their mitochondrial phenotype and examples of the three groups are shown. 
The distribution among the three categories was compared between untreated cells (ctrl) 
and cells exposed to 3 or 14 days of EtOH (D3, D14. 300 cells counted, *P < 0.05; scale 
bar= 10µm). B: Intracellular structure (N, nuclei) and megamitochondria (M) development 
were analyzed in untreated (ctrl) or in day3/day14 EtOH cultures. Representative electron 
micrographs show a mix of fragmented (circled areas) and elongated (squared areas) 
organelles in the ctrl and fragmented or megamitochondria (M; width, length >1µm; scale 
bar= 2µm) after EtOH exposure, especially at D14 of treatment. The graph shows the 
distribution of the size of megamitochondria in approx. 100 cells.   
 
Figure 2. Ethanol (EtOH) exposure moderately reduces cell viability and severely 
affects cell growth, with no impact on mitochondrial respiration and mitochondrial 
mass in VL-17A hepatoma cell line. A: Cell growth rate decreases during culture in the 
presence of EtOH compared to the ctrl (mean ± SEM; n=4, *P < 0.05). B: EtOH induces 
growth arrest as shown by changes in CellTrace dye fluorescence (mean ± SEM; n=4). C: 
Apoptotic (Annexin-V(+)) and necrotic (Propidium Iodide(+)) cells (positive cells) were 
quantified after 3 days (D3, mean ± SEM; n=12; P > 0.05) or 14 days (D14, mean ± SEM; 
n=7; *P < 0.05) of EtOH exposure and compared to the untreated controls (ctrl). The longer 
treatment induces a small but significant increase in apoptosis. D: The mitochondrial 
functionality was investigated quantifying the oxygen consumption rate (OCR) in response to 
oligomycin, FCCP, or antimycin A and no significant differences are reported between the 
control and the EtOH-treated cells (mean ± SEM; n=3, P > 0.05). E: The coupling efficiency 
and spare respiratory capacity were calculated and no significant difference is observed 
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between EtOH and ctrl (mean ± SEM; n=3). F: The mitochondrial mass was analyzed after 
D3/D14 EtOH exposure with no differences detected (mean ± SEM; n=3).  
 
Figure 3. Ethanol (EtOH) exposure perturbs the Drp1 pathway in VL-17A cells. A: 
Mitochondrial fragmentation: The expression or localization of Drp1 and its receptors (Mff, 
MiD51) were analyzed in the ethanol cultures after 3 or 14 days (n>3; D3, P > 0.05 and D14, 
*P < 0.05 compared to ctrl). B:  Mitochondrial fusion: The expression of Mitofusin-1 (Mfn1) 
and Mitofusin-2 (Mfn2) was evaluated in untreated VL-17A cells (Ct) and after 3 or 14 days 
of EtOH exposure (n>3; D3, D14. P > 0.05). C: The hepatic expression of Drp1 was 
analyzed on WT mice fed with control or ethanol diet (n=4). In all panels representative 
western blots are shown along with the densitometric analysis (mean ± SEM). 
 
Figure 4. Drp1 inactivation promotes megamitochondria formation and reduces 
ethanol-induced toxicity in hepatoma cells. A: Approx. 120 cells (positive for mtRFP and 
expressing Drp1-K38A (inactive form)) with/without 3days of EtOH exposure were sorted 
into three categories according to their mitochondrial morphology (hyper-
fused/megamitochondria, mixed network, or hyper-fragmented) and a big proportion of cells 
with megamitochondria is detected (*P < 0.05). B: The three mitochondrial phenotypes were 
analyzed in VL-17A cells expressing WT Drp1 and positive for mtRFP (approx. 300 cells 
counted per condition). The distribution is different after 3 days of EtOH exposure (D3) 
compared to control (*P < 0.05). C: In VL-17A stably expressing eGFP (WT Drp1) or co-
expressing eGFP and Drp1-K38A (Drp1-K38A) the number of GFP+ cells was quantified 
during 14 days of EtOH exposure. A significant increase is detected only in Drp1-K38A, but 
not in WT Drp1 (mean ± SEM; n=3; *P < 0.05).  
 
Figure 5. Ethanol exposure causes megamitochondria development in mice and 
hepatic Drp1 inactivation increases this effect and reduces ethanol-induced 
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hepatotoxicity. Megamitochondria formation was analyzed in mice with liver inactivation of 
Drp1 (Alb-Cre+Drp1) and compared to WT mice (Alb-Cre-Drp1) exposed to control or ethanol 
diet. A, B: Representative electron micrographs show examples of megamitochondria (M, 
megamitochondria: width, length >2µm; LD, lipid droplets; N, nucleus; scale bars= 1 µm) in 
Alb-Cre-Drp1 (A) and Alb-Cre+Drp1 (B) fed with control or ethanol diet. C: The percentage of 
megamitochondria in Alb-Cre-Drp1 and Alb-Cre+Drp1 was quantified: a significant increase 
after ethanol exposure is seen in both groups and this effect significantly exacerbates after 
Drp1 inactivation (n>3; mean ± SEM; >360 mitochondria analyzed; *P < 0.05 vs Alb-Cre-
Drp1 ctrl diet; †P < 0.05 vs Alb-Cre+Drp1 ethanol diet). D: ALT levels in the blood of Alb-Cre-
Drp1 and Alb-Cre+Drp1 mice after exposure to ethanol were quantified and the ratios versus 
ALT in mice fed with control diet shown (ratio of mean ± error propagation; n>3; *P < 0.05).     
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